A Phase I Study of Pemetrexed (LY231514, Alimta) in Children and Adolescents With Recurrent Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 23 Aug 2010
At a glance
- Drugs Pemetrexed (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 22 Aug 2006 Status change
- 24 Aug 2005 New trial record.